Activation of the erythrocyte plasma membrane redox system by resveratrol: A possible mechanism for antioxidant properties

Pharmacological Reports

Volumn 62, Issue 4, 2010, Pages 726-732

  Rizvi, Syed Ibrahim ^a   Pandey, Kanti Bhooshan ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

AFR reductase; Antioxidant; Erythrocyte; PMRS; Resveratrol

Indexed keywords

ASCORBATE FREE RADICAL REDUCTASE; OXIDOREDUCTASE; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LEVEL; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ELECTRON TRANSPORT; ENZYME ACTIVATION; ERYTHROCYTE MEMBRANE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; MALE; OXIDATION REDUCTION REACTION;

EID: 77958012175     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70330-3     Document Type: Article

References (37)

1. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA, 1993, 90, 7915-7922.
2. Avron M, Shavit N: A sensitive and simple method for determination of ferrocyanide. Anal Biochem, 1963, 6, 549-554.
3. Bertelli AAE, Giovannini L, Stradi R, Bertelli A, Tillement J-P: Plasma, urine and tissue levels of trans-and cis-resveratrol (3,4',5-trihydroxystilbene) after shortterm or prolonged administration of red wine to rats. Int J Tissue React, 1996, 18, 67-71.
4. Bertelli AAE: Modulatory effect of resveratrol, a natural phytoalexin, on endothelial adhesion molecules and intracellular signal transduction. Pharm Biol, 1998, 36, 44-52.
5. Cao Z, Fang J, Xia C, Shi X, Jiang BH: trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1α and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res, 2004, 10, 5253-5263.
6. Cao Z, Li Y: Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol, 2004, 489, 39-48.
7. Caruso F, Tanski J, Villegas-Estrada A, Rossi M: Structural basis for antioxidant activity of trans-resveratrol: Ab initio calculations and crystal and molecular structure. J Agric Food Chem, 2004, 52, 7279-7285.
8. Clemens MR, Waller HD: Lipid peroxidation in erythrocytes. Chem Phys Lipids, 1987, 45, 251-268.
9. Fernández-Pachón MS, Villań;o D, García-Parrilla MC, Troncoso AM: Antioxidant activity of wines and relation with their polyphenolic composition. Anal Chim Acta, 2004, 513, 113-118.
10. Fiorani M, Accorsi A: Dietary flavonoids as intracellular substrates for an erythrocyte trans-plasma membrane oxidoreductase activity. Br J Nutr, 2005, 94, 338-345.
11. Fiorani M, De Sanctis R, De Bellis R, Dacha M: Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes. Free Radic Biol Med, 2002, 32, 64-72.
12. Fremont L: Biological effects of resveratrol. Life Sci, 2000, 66, 663-673.
13. Granados-Soto V: Pleiotropic effects of resveratrol. Drugs News Perspect, 2003, 16, 299-307.
14. Gusman J, Malonne H, Atassi GA: Reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, 2001, 22, 1111-1117.
15. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford University Press, Oxford, 1989.
16. Harikumar KB, Aggarwal BB: Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle, 2008, 8, 1020-1035.
17. 13C-NMR studies of transemembrane electron transfer to extracellular ferricynide in human erythrocytes. Eur J Biochem, 1997, 246, 638-645.
18. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res, 2000, 47, 549-555.
19. Jannin B, Menzel M, Berlot J-P, Delmas D, Lançon A, Latruffe N: Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol, 2004, 68, 1113-1118.
20. Kennett EC, Kuchel PW: Plasma membrane oxidoreductases: Effects on erythrocyte metabolism and redox homeostasis. Antiox Redox Signal, 2006, 8, 1241-1247.
21. Leonard SS, Xia C, Jiang B-H, Stinefelt B, Klandorf H, Harris GK, Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun, 2003, 309, 1017-1026.
22. Mahal HS, Mukherjee T: Scavenging of reactive oxygen radicals by resveratrol: antioxidant effect. Res Chem Intermed, 2006, 32, 59-71.
23. May JM, Qu ZC: Ascorbate-dependent electron transfer across the human erythrocytes membrane. Biochim Biophys Acta, 1999, 1421, 19-31.
24. May JM, Qu ZC, Cobb CE: Extracellular reduction of ascorbate free radical by human erythrocytes, Biochem Biophys Res Commun, 2000, 267, 118-123.
25. May JM, Qu ZC, Cobb CE: Human erythrocyte recycling of ascorbic acid. J Biol Chem, 2004, 279, 14975-14982.
26. May JM, Qu ZC, Cobb CE: Recycling of the ascorbate free radical by human erythrocyte membranes, Free Radic Biol Med, 2001, 31, 117-124.
27. May JM, Qu ZC, Whitesell RR: Ascorbate is the major electron donor for a transmembrane oxidoreductase of human erythrocytes. Biochim Biophys Acta, 1995, 1238, 127-136.
28. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A: Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep, 2009, 61, 67-75.
29. Rice Evans C, Miller NJ, Paganga G: Structureantioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med, 1996, 20, 933-956.
30. Rizvi SI, Jha R, Maurya PK: Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res, 2006, 9, 470-474.
31. Rizvi SI, Pandey KB, Jha R, Maurya PK: Ascorbate recycling by erythrocytes during aging in humans. Rejuvenation Res, 2009, 12, 3-6.
32. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L et al.: Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem, 2001, 276, 22586-22594.
33. Su D, May JM, Koury MJ, Asard H: Human erythrocyte membranes contain a cytochrome b561 that may be involved in extracellular ascorbate recycling. J Biol Chem, 2006, 281, 39852-39859.
34. Tedesco I, Russo M, Russo P, Iacomino G, Russo GL, Carraturo A, Faruolo C et al.: Antioxidant effect of red wine polyphenols on red blood cells. J Nutr Biochem, 2000, 11, 114-119.
35. Van Duijn MM, Tijssen K, Van Steveninck J, Van Den Broek PJ, Van Der Zee J: Erythrocytes reduce extracellular ascorbate free radicals using intracellular ascorbate as an electron donor. J Biol Chem, 2000, 275, 27720-27725.
36. Van Duijn MM, Van der Zee J, Van den Broek PJ: The ascorbate-driven reduction of extracellular ascorbate free radical by the erythrocyte is an electrogenic process. FEBS Lett, 2001, 491, 67-70.
37. Wright JS, Johnson ER, DiLabio GA: Predicting the activity of phenolic antioxidants: theoretical method, analysis of substituent effects, and application to major families of antioxidants. J Am Chem Soc, 2001, 123, 1173-1183.